YHB Investment Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-772
Closed -$232K 197
2018
Q4
$232K Sell
772
-45
-6% -$14.4K 0.04% 164
2018
Q3
$289K Sell
817
-5
-0.6% -$1.72K 0.04% 163
2018
Q2
$239K Sell
822
-50
-6% -$14.1K 0.04% 171
2018
Q1
$239K Buy
872
+45
+5% +$14K 0.04% 171
2017
Q4
$263K Sell
827
-70
-8% -$22.5K 0.04% 167
2017
Q3
$281K Buy
+897
New +$266K 0.05% 155

Other funds holding BIIB

YHB Investment Advisors's BIIB Position: Q1 2019 in Review

YHB Investment Advisors sold out of Biogen (BIIB) in Q1 2019, closing a stake of 772 shares — an estimated $232K sold.

YHB Investment Advisors first reported a position in BIIB in Q3 2017 and held it in 6 quarters. The position peaked at $289K in Q3 2018. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • YHB Investment Advisors reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • YHB Investment Advisors sold 772 Biogen shares in Q1 2019, an estimated $232K.
  • YHB Investment Advisors first reported a position in Biogen in Q3 2017 and held it in 6 quarters.
  • YHB Investment Advisors's Biogen position peaked at $289K in Q3 2018.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on YHB Investment Advisors's 13F filing for Q1 2019, filed 29 Apr 2019.